Nick Curzen
Professor of Interventional Cardiology, Consultant
Haematology
Haemonetics
Sweden
Biography
Dr. Curzen focuses on coronary intervention and trans-catheter aortic valve implantation (TAVI). He has an active research team focusing on coronary physiology, computer modelling in coronary stents and TAVI, and platelet function. He is currently Chief Investigator for two large randomized trials in the UK: RIPCORD 2 and FORECAST. Previously, he was Chief Investigator for RIPCORD 1, FFRCT RIPCORD and COMET. Dr. Curzen has led a platelet function research team for over 10 years looking at personalized antiplatelet medication, and has published widely in this field using TEG 5000. More recently, the team has just finished a validation study for the TEG 6s. He has published over 200 PubMed papers and edited three textbooks, including the Oxford Textbook of Interventional Cardiology.
Research Interest
Haematology
